LONDON, June 22, 2017 (GLOBE NEWSWIRE) -- The global bioactive wound care market is expected to grow at a CAGR of 8.7% in the first half of the forecast period and CAGR of 7.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 8.0% from 2017 to 2027. The market is estimated at $4,825 million in 2016, $8,052 million in 2021, and $12,420 million in 2027.
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 213-page report you will receive 100 tables and 103 figures– all unavailable elsewhere.
The 213-page visiongain report provides clear detailed insight into the global bioactive wound care market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
To see a free report overview please email sara.peerun@visiongain.com
Report Scope
• Global Bioactive Wound Care Market forecasts from 2017-2027
• Moist Wound Care submarket forecasts from 2017-2027, further segmented into:
- Alginate Dressings
- Hydrocolloid Dressings
This section also discusses the leading product as well as SWOT analysis of this submarket.
• Biological Wound Care submarket forecasts from 2017-2027, further segmented into:
- Skin Substitutes
- Collagen Dressings
- Cell Based Therapy
- Others
This section also discusses the leading product as well as SWOT analysis of this submarket.
• Antimicrobial Wound Care submarket forecasts from 2017-2027, further segmented into:
- Silver-Based
- Iodine-Based
- Chitosan-Based
- Others
This section also discusses the leading product as well as SWOT analysis of this submarket.
• Bioactive Wound Care Leading Regional Market forecasts from 2017-2027 covering North America, Western Europe, Eastern Europe, Asia-Pacific, Latin America, Middle East and Africa.
Each region is further segmented into the submarkets of moist wound care, biological wound care and antimicrobial wound care.
• Bioactive Wound Care forecasts by country from 2017-2027, covering:
- United States
- Canada
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Poland
- China
- South Korea
- Japan
- India
- Australia
- New Zealand
- Brazil
- Mexico
- Saudi Arabia
- Turkey
- Israel
- South Africa
• Assessment of selected leading companies that hold major market shares in the bioactive wound care market.
Visiongain’s study is intended for anyone requiring commercial analyses for the Bioactive Wound Care Market. You find data, trends and predictions.
To see a free report overview please email sara.peerun@visiongain.com
Companies Listed in this report include:
3M
Acelity
Advanced BioHealing (ABH)
Anika Therapeutics
ArchiMed
Aspen Medical
Avista Capital Partners
Avita Medical
B. Braun Melsungen AG
Bristol-Myers Squibb (BMS)
Centres of Disease Control and Preventions
Coloplast A/S
ConvaTec
Covalon
Covidien
Dr. Suwelack Skin & Health Care
European Wound Management Association (EWMA)
Food and Drug Administration (FDA)
Forticell Bioscience
Genzyme
Healthpoint Biotherapeutics
Human BioScience
Innocoll
Integra Life Science
Kaken Pharmaceutical
KCI
Lescarden
LifeCell
Medline
Medtronic, plc
MiMedX
Mölnlycke
MundiPharma Medical Company
Nordic Capital Partners
Organogenesis
Osiris Therapeutics
Paul Hartmann AG
Promethean
Rochal Industries
Shire
Sinanen Zeomic
Smith & Nephew
Systagenix
Trusetal Verbandstoffwerk GmbH
World Health Organization (WHO)
Wound Management Technologies
To see a free report overview please email sara.peerun@visiongain.com